Bronchodilator Syrup in pharma franchise in Arunachal Pradesh

Bronchodilator Syrup in PCD pharma franchise in Lucknow

Bronchodilator Syrup in top pharma company in Pune

Bronchodilator Syrup in pcd pharma supplier in Kanpur

Bronchodilator Syrup in phama franchise company in India
Bronchodilator Syrup in phama distributor in Indore

Home/Products /terbutaline-1-point-25mg-5ml-acebrophylline-50mg-5ml-guaifenesin-50mg-5ml-syrup

Abrostep Plus Syrup

Composition : Terbutaline (1.25mg/5ml) + Acebrophylline (50mg/5ml) + Guaifenesin (50mg/5ml) Syrup

Dosage Form : Syrup

Packaging Type : with Carton and Measuring Cap

Packaging : 100 ml

Price : ₹139/-

Abrostep Plus Syrup is an effective combination of Terbutaline (1.25mg/5ml), Acebrophylline (50mg/5ml), and Guaifenesin (50mg/5ml), specifically formulated to address respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and productive cough. This syrup works through a synergistic mechanism to provide relief from bronchospasms, ease mucus expulsion, and improve overall respiratory function.

  • Terbutaline is a bronchodilator that relaxes airway muscles, alleviating bronchospasms and facilitating better airflow.
  • Acebrophylline combines mucolytic and anti-inflammatory properties, reducing mucus production and swelling in the airways to enhance respiratory efficiency.
  • Guaifenesin acts as an expectorant, loosening and thinning mucus in the airways, making it easier to cough up and clear the respiratory tract.

This triple-action formula not only eases breathing difficulties but also promotes faster recovery from respiratory distress by addressing airway inflammation and mucus build-up. Its formulation makes it suitable for patients experiencing conditions like asthma, bronchitis, or other obstructive airway diseases.

Read More

About the Product

Abrostep Plus Syrup is an effective combination of Terbutaline (1.25mg/5ml), Acebrophylline (50mg/5ml), and Guaifenesin (50mg/5ml), specifically formulated to address respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and productive cough. This syrup works through a synergistic mechanism to provide relief from bronchospasms, ease mucus expulsion, and improve overall respiratory function.

  • Terbutaline is a bronchodilator that relaxes airway muscles, alleviating bronchospasms and facilitating better airflow.
  • Acebrophylline combines mucolytic and anti-inflammatory properties, reducing mucus production and swelling in the airways to enhance respiratory efficiency.
  • Guaifenesin acts as an expectorant, loosening and thinning mucus in the airways, making it easier to cough up and clear the respiratory tract.

This triple-action formula not only eases breathing difficulties but also promotes faster recovery from respiratory distress by addressing airway inflammation and mucus build-up. Its formulation makes it suitable for patients experiencing conditions like asthma, bronchitis, or other obstructive airway diseases.

Common side effects include nausea, headache, mild tremors, or an upset stomach. Consult a healthcare provider if side effects persist or worsen.

Indicated for the management of asthma, COPD, and productive cough by improving airway function and facilitating mucus clearance.

Use under medical supervision, especially for individuals who are pregnant, breastfeeding, or on other medications. Avoid exceeding the prescribed dose.

Store in a cool, dry place below 30°C. Protect from direct sunlight and keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation